Celyad Oncology SA (CLYYF)
OTCMKTS · Delayed Price · Currency is USD
0.1500
-0.0300 (-16.67%)
At close: Dec 26, 2025
Celyad Oncology Market Cap
Celyad Oncology has a market cap or net worth of $14.45 million as of February 12, 2026. Its market cap has decreased by -21.83% in one year.
Market Cap
14.45M
Enterprise Value
14.50M
Revenue
218.44K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.15
Market Cap Chart
Since July 4, 2013, Celyad Oncology's market cap has decreased from 131.80M to 14.45M, a decrease of -89.04%. That is a compound annual growth rate of -16.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 14.45M | 61.71% |
| Dec 31, 2025 | 8.93M | -70.74% |
| Dec 31, 2024 | 30.54M | 71.00% |
| Dec 29, 2023 | 17.86M | 46.17% |
| Dec 30, 2022 | 12.22M | -86.47% |
| Dec 31, 2021 | 90.32M | -20.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inhibitor Therapeutics | 13.60M |
| HOOKIPA Pharma | 13.25M |
| TRON Group | 11.43M |
| AccuStem Sciences | 10.19M |
| Biomind Labs | 8.84M |
| Zenith Capital | 7.99M |
| Curative Biotechnology | 7.87M |
| NKGen Biotech | 7.84M |